This theoretical article revives a classical bridging construct, canalization, to describe a new
model of a general factor of psychopathology. To achieve this, we have distinguished …

Background and aims Ingestion or administration of classic psychedelics is sometimes
associated with improvements in well-being or mental health. Acute mystical-type …

Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to
highly challenging (eg, fear, grief, and paranoia). These challenging experiences contribute …

Background Psilocybin therapy is receiving attention as a mental health intervention with
transdiagnostic potential. In line with psychotherapeutic research, qualitative research has …

Background: Growing numbers of people are using psychedelics for personal
psychotherapy outside clinical settings, but research on such use is scarce. Aims: This study …

Background: Over the last two decades, a number of studies have highlighted the potential
of psychedelic therapy. However, questions remain to what extend these results translate to …

Psilocybin, a serotonergic psychedelic, is being increasingly researched in clinical studies
for the treatment of psychiatric disorders. The relatively lengthy duration of oral psilocybin's …

BackgroundMajor depressive disorder is often associated with maladaptive coping
strategies, including rumination and thought suppression. AimsTo assess the comparative …

Recent research has demonstrated the potential of psychedelic therapy for mental health
care. However, the psychological experience underlying its therapeutic effects remains …

Objective Body dysmorphic disorder (BDD) is an often-severe condition in which individuals
are preoccupied by misperceptions of their appearance as defective or ugly. Only serotonin …